Gaskiya Diagnostics builds rapid diagnostic tests that let aquaculture farmers quickly identify disease in their stock without specialized training or equipment. Its tests aim to enable faster treatment, reduce losses, and increase food quality for a $250 billion/year aquaculture market. The company is in accelerated product development and is expanding its team to expedite and broaden product development to meet customer needs. Gaskiya joined Delaware Innovation Space as a resident company and is using shared facilities and lent equipment to scale lab work quickly. Mary Larkin, PhD, is the company's CEO and has said the First Fund investment is meeting several critical needs for growth. The company currently sells to or serves farmers (end users) by providing accessible on-farm diagnostics designed for users of all skill levels.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2020